Neogen Corporation NG2.F Stock
Neogen Corporation Price Chart
Neogen Corporation NG2.F Financial and Trading Overview
Neogen Corporation stock price | 11.9 EUR |
Previous Close | 17.7 EUR |
Open | 17.9 EUR |
Bid | 17.9 EUR x 40000 |
Ask | 18.4 EUR x 40000 |
Day's Range | 17.9 - 17.9 EUR |
52 Week Range | 10.8 - 23.6 EUR |
Volume | 20 EUR |
Avg. Volume | 8 EUR |
Market Cap | 3.87B EUR |
Beta (5Y Monthly) | 0.988028 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0.02 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 55 EUR |
NG2.F Valuation Measures
Enterprise Value | 4.62B EUR |
Trailing P/E | N/A |
Forward P/E | 23.866667 |
PEG Ratio (5 yr expected) | 6.74 |
Price/Sales (ttm) | 5.3700495 |
Price/Book (mrq) | 1.2383258 |
Enterprise Value/Revenue | 6.409 |
Enterprise Value/EBITDA | 37.4 |
Trading Information
Neogen Corporation Stock Price History
Beta (5Y Monthly) | 0.988028 |
52-Week Change | -19.19% |
S&P500 52-Week Change | 20.43% |
52 Week High | 23.6 EUR |
52 Week Low | 10.8 EUR |
50-Day Moving Average | 15.8 EUR |
200-Day Moving Average | 15.8 EUR |
NG2.F Share Statistics
Avg. Volume (3 month) | 8 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 216.22M |
Float | 216.01M |
Short Ratio | N/A |
% Held by Insiders | 0.076% |
% Held by Institutions | 101.13% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | May 31, 2022 |
Most Recent Quarter (mrq) | February 28, 2023 |
Next Fiscal Year End | May 31, 2023 |
Profitability
Profit Margin | -1.87% |
Operating Margin (ttm) | 8.00% |
Gross Margin | 48.25% |
EBITDA Margin | 17.13% |
Management Effectiveness
Return on Assets (ttm) | 1.31% |
Return on Equity (ttm) | -0.67% |
Income Statement
Revenue (ttm) | 720.73M EUR |
Revenue Per Share (ttm) | 4.46 EUR |
Quarterly Revenue Growth (yoy) | 70.19% |
Gross Profit (ttm) | 243.01M EUR |
EBITDA | 123.52M EUR |
Net Income Avi to Common (ttm) | -13483000 EUR |
Diluted EPS (ttm) | -0.02 |
Quarterly Earnings Growth (yoy) | 50.50% |
Balance Sheet
Total Cash (mrq) | 185.9M EUR |
Total Cash Per Share (mrq) | 0.86 EUR |
Total Debt (mrq) | 891.79M EUR |
Total Debt/Equity (mrq) | 28.53 EUR |
Current Ratio (mrq) | 5.183 |
Book Value Per Share (mrq) | 14.455 |
Cash Flow Statement
Operating Cash Flow (ttm) | -29548000 EUR |
Levered Free Cash Flow (ttm) | -60182876 EUR |
Profile of Neogen Corporation
Country | Germany |
State | MI |
City | Lansing |
Address | 620 Lesher Place |
ZIP | 48912 |
Phone | 517 372 9200 |
Website | https://www.neogen.com |
Industry | Diagnostics & Research |
Sector(s) | Healthcare |
Full Time Employees | 2108 |
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
Q&A For Neogen Corporation Stock
What is a current NG2.F stock price?
Neogen Corporation NG2.F stock price today per share is 11.9 EUR.
How to purchase Neogen Corporation stock?
You can buy NG2.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Neogen Corporation?
The stock symbol or ticker of Neogen Corporation is NG2.F.
Which industry does the Neogen Corporation company belong to?
The Neogen Corporation industry is Diagnostics & Research.
How many shares does Neogen Corporation have in circulation?
The max supply of Neogen Corporation shares is 216.61M.
What is Neogen Corporation Price to Earnings Ratio (PE Ratio)?
Neogen Corporation PE Ratio is 595.00000000 now.
What was Neogen Corporation earnings per share over the trailing 12 months (TTM)?
Neogen Corporation EPS is 0.02 EUR over the trailing 12 months.
Which sector does the Neogen Corporation company belong to?
The Neogen Corporation sector is Healthcare.